MX369094B - Metodos para sintetizar un analogo de prostaciclina. - Google Patents

Metodos para sintetizar un analogo de prostaciclina.

Info

Publication number
MX369094B
MX369094B MX2015006972A MX2015006972A MX369094B MX 369094 B MX369094 B MX 369094B MX 2015006972 A MX2015006972 A MX 2015006972A MX 2015006972 A MX2015006972 A MX 2015006972A MX 369094 B MX369094 B MX 369094B
Authority
MX
Mexico
Prior art keywords
processes
present
generate
traditional methods
methods
Prior art date
Application number
MX2015006972A
Other languages
English (en)
Other versions
MX2015006972A (es
Inventor
Chambournier Gilles
William Hering Kirk
William Endres Gregory
Fedij Victor
James Krell Ii Thomas
Mahmoud Mahmoud Hussein
Original Assignee
Cayman Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cayman Chemical Co Inc filed Critical Cayman Chemical Co Inc
Publication of MX2015006972A publication Critical patent/MX2015006972A/es
Publication of MX369094B publication Critical patent/MX369094B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/34Separation; Purification; Stabilisation; Use of additives
    • C07C41/44Separation; Purification; Stabilisation; Use of additives by treatments giving rise to a chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/32Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/14Benz[f]indenes; Hydrogenated benz[f]indenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invención proporciona procesos para preparar un análogo de la prostaciclina de Fórmula I (ver Fórmula) o una de sus sales farmacéuticamente aceptables, donde R10 es un alquilo C1-6 lineal o ramificado. Los procesos de la presente invención comprenden pasos para generar rendimientos mejorados y menos subproductos que los métodos tradicionales. Los procesos de la presente invención emplean reactivos (p. ej., el reactivo oxidante) que son menos tóxicos que los que se emplean en los métodos tradicionales (p. ej., cloruro de oxalilo). Muchos de los procesos de la presente invención generan intermediarios con un e.e. y una pureza química mejorados; mediante los cuales se prescinde de pasos cromatográficos adicionales. Además, los procesos de la presente invención se pueden escalar para generar cantidades comerciales del compuesto final.
MX2015006972A 2012-12-07 2013-12-06 Metodos para sintetizar un analogo de prostaciclina. MX369094B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261734672P 2012-12-07 2012-12-07
US201361777882P 2013-03-12 2013-03-12
PCT/US2013/073474 WO2014089385A2 (en) 2012-12-07 2013-12-06 Methods of synthesizing a prostacyclin analog

Publications (2)

Publication Number Publication Date
MX2015006972A MX2015006972A (es) 2016-02-11
MX369094B true MX369094B (es) 2019-10-29

Family

ID=49881039

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015006972A MX369094B (es) 2012-12-07 2013-12-06 Metodos para sintetizar un analogo de prostaciclina.
MX2019009102A MX2019009102A (es) 2012-12-07 2015-06-02 Metodos para sintetizar un analogo de prostaciclina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019009102A MX2019009102A (es) 2012-12-07 2015-06-02 Metodos para sintetizar un analogo de prostaciclina.

Country Status (21)

Country Link
US (4) US20150315114A1 (es)
EP (2) EP3398931B1 (es)
JP (2) JP6342414B2 (es)
KR (1) KR20150091170A (es)
CN (3) CN104837806A (es)
AU (2) AU2013355130B2 (es)
BR (1) BR112015013085A2 (es)
CA (1) CA2893604A1 (es)
CL (1) CL2015001535A1 (es)
DK (1) DK2928858T3 (es)
EA (1) EA034309B1 (es)
ES (1) ES2664026T3 (es)
HK (1) HK1212323A1 (es)
IL (1) IL239172B (es)
MX (2) MX369094B (es)
NZ (1) NZ708130A (es)
PE (1) PE20160090A1 (es)
PH (2) PH12015501258A1 (es)
SG (2) SG10201600303WA (es)
TW (1) TWI634104B (es)
WO (1) WO2014089385A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201600303WA (en) * 2012-12-07 2016-02-26 Cayman Chemical Co Inc Methods Of Synthesizing A Prostacyclin Analog
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
EP3068752A1 (en) * 2013-11-13 2016-09-21 Cayman Chemical Company Incorporated Amine salts of a prostacyclin analog
HU231186B1 (hu) 2014-10-08 2021-06-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás treprostinil és sói előállítására
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
JP7220650B2 (ja) 2016-09-26 2023-02-10 ユナイテッド セラピューティクス コーポレイション トレプロスチニルプロドラッグ
EP3498283A1 (en) 2017-12-14 2019-06-19 Ipsol AG Glycosidic derivatives of treprostinil
HU231296B1 (hu) * 2018-03-09 2022-09-28 Chinoin Zrt Eljárás treprostinil-dietanol-amin só B polimorf formájának előállítására
CA3149358A1 (en) 2019-08-23 2021-03-04 United Therapeutics Corporation Treprostinil prodrugs
KR20230011929A (ko) 2020-04-17 2023-01-25 유나이티드 쎄러퓨틱스 코포레이션 간질성 폐 질환의 치료에 사용하기 위한 트레프로스티닐
CN116113415A (zh) 2020-06-09 2023-05-12 联合治疗公司 曲前列尼尔的富马酰基二酮哌啶前药
KR20220030006A (ko) 2020-09-02 2022-03-10 바이오플러스 주식회사 미용 조성물을 포함하는 마스크 및 그 제조 방법
WO2022132655A1 (en) 2020-12-14 2022-06-23 United Therapeutics Corporation Methods of treating disease with treprostinil prodrugs

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306075A (en) 1980-03-28 1981-12-15 The Upjohn Company Composition and process
CA2039857A1 (en) * 1990-04-26 1991-10-27 Wilfred Po-Sum Shum Process for producing epoxyalcohols of high optical purity
US6441245B1 (en) 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US6700025B2 (en) 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
CN101780092B (zh) * 2003-05-22 2012-07-04 联合治疗公司 化合物和释放前列环素类似物的方法
EP2177526A4 (en) * 2007-08-06 2012-08-22 Taisho Pharmaceutical Co Ltd 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12
ES2630407T3 (es) 2007-12-17 2017-08-21 United Therapeutics Corporation Procedimiento mejorado para preparar treprostinil, el principio activo en Remodulin®
WO2010039531A1 (en) * 2008-09-23 2010-04-08 Resolvyx Pharmaceuticals, Inc. Therapeutic compounds
CN101891596B (zh) * 2009-05-22 2013-12-11 上海天伟生物制药有限公司 一种化合物及其制备方法和用途
CN103261142B (zh) 2010-06-03 2014-12-10 联合治疗公司 曲前列环素的制备
CA2710726C (en) * 2010-07-22 2016-02-23 Alphora Research Inc. Synthesis of treprostinil and intermediates useful therein
WO2012041334A1 (en) 2010-10-01 2012-04-05 Rigshospitalet Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest
JP5199519B2 (ja) * 2010-11-30 2013-05-15 独立行政法人科学技術振興機構 ヌクレオシド類縁体又はその塩、オリゴヌクレオチド類縁体、遺伝子発現抑制剤、及び遺伝子検出用核酸プローブ
US8524939B2 (en) 2011-08-24 2013-09-03 Chirogate International Inc. Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
CN102796134B (zh) * 2012-08-31 2015-07-01 甘肃皓天化学科技有限公司 一种马沙骨化醇中间体的制备方法
SG10201600303WA (en) * 2012-12-07 2016-02-26 Cayman Chemical Co Inc Methods Of Synthesizing A Prostacyclin Analog
EP3068752A1 (en) * 2013-11-13 2016-09-21 Cayman Chemical Company Incorporated Amine salts of a prostacyclin analog

Also Published As

Publication number Publication date
CN107098925A (zh) 2017-08-29
US20150315114A1 (en) 2015-11-05
BR112015013085A2 (pt) 2017-07-11
AU2013355130B2 (en) 2018-06-21
SG10201600303WA (en) 2016-02-26
EP2928858A2 (en) 2015-10-14
US10450257B2 (en) 2019-10-22
US9908834B2 (en) 2018-03-06
AU2018233009B2 (en) 2020-01-23
PH12018500562A1 (en) 2019-03-04
US20170297995A1 (en) 2017-10-19
EA034309B1 (ru) 2020-01-27
IL239172B (en) 2020-01-30
PH12015501258B1 (en) 2015-08-17
JP2016504303A (ja) 2016-02-12
IL239172A0 (en) 2015-07-30
NZ708130A (en) 2020-01-31
PE20160090A1 (es) 2016-02-20
MX2019009102A (es) 2019-09-16
US20180141889A1 (en) 2018-05-24
WO2014089385A2 (en) 2014-06-12
ES2664026T3 (es) 2018-04-18
TW201422577A (zh) 2014-06-16
KR20150091170A (ko) 2015-08-07
US20200002261A1 (en) 2020-01-02
CN104837806A (zh) 2015-08-12
DK2928858T3 (en) 2018-02-19
JP6342414B2 (ja) 2018-06-13
EP3398931B1 (en) 2020-04-08
SG11201504430TA (en) 2015-07-30
JP2018162250A (ja) 2018-10-18
TWI634104B (zh) 2018-09-01
EP3398931A1 (en) 2018-11-07
CA2893604A1 (en) 2014-06-12
PH12015501258A1 (en) 2015-08-17
EA201591093A1 (ru) 2015-09-30
AU2018233009A1 (en) 2018-10-18
MX2015006972A (es) 2016-02-11
WO2014089385A3 (en) 2014-08-28
EP2928858B1 (en) 2018-01-31
HK1212323A1 (en) 2016-06-10
CL2015001535A1 (es) 2016-01-15
AU2013355130A1 (en) 2015-06-11
CN107098925B (zh) 2019-09-13
CN110590547A (zh) 2019-12-20

Similar Documents

Publication Publication Date Title
PH12018500562A1 (en) Methods of synthesizing a prostacyclin analog
EA202090917A1 (ru) Получение псилоцибина, различных полиморфных форм, промежуточных соединений, составов и их применение
PH12015502839A1 (en) Antiviral compounds
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
NZ603268A (en) Process for synthesizing oxidized lactam compounds
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
TW201240990A (en) Antiviral compounds
MX350892B (es) Síntesis de compuesto antiviral.
MX2019003738A (es) Compuestos antivirales.
MX2013011257A (es) Proceso para la preparacion de dronedarona por n-butilacion.
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
IN2014MN01521A (es)
IN2014DN00144A (es)
IN2014KN01062A (es)
EA201391721A1 (ru) Способ получения полиморфной формы i эторикоксиба
MY160954A (en) Agomelatine intermediates and preparation method thereof
MX2013000294A (es) Intermedios y procedimiento de preparación de un inhibidor específico de la trombina.
MX2017009839A (es) Proceso para la produccion de derivados de imidazolo condensados.
IN2013DE00241A (es)
IN2014DN09251A (es)
EA201992455A3 (ru) Способы синтеза аналога простациклина
IN2013CH05689A (es)
MX2012013730A (es) Sintesis por electrocarboxilacion para obtener intermedios utiles para la sintesis de derivados de span.
IN2013MU03379A (es)
MX2012001535A (es) Proceso para la fabricacion de 2-pentin-1-ol.

Legal Events

Date Code Title Description
FG Grant or registration